CN Patent

CN108366965A — 稳定喜树碱药物组合物

Assigned to Ipsen Biopharm Ltd · Expires 2018-08-03 · 8y expired

What this patent protects

提供具有改善的储存稳定性的伊立替康磷脂脂质体，以及相关的治疗和制备方法。伊立替康脂质体在储存过程中以及在施用于患者之前可以减少溶血磷脂酰胆碱(溶血‑PC)的形成。

USPTO Abstract

提供具有改善的储存稳定性的伊立替康磷脂脂质体，以及相关的治疗和制备方法。伊立替康脂质体在储存过程中以及在施用于患者之前可以减少溶血磷脂酰胆碱(溶血‑PC)的形成。

Drugs covered by this patent

Patent Metadata

Patent number
CN108366965A
Jurisdiction
CN
Classification
—
Expires
2018-08-03
Drug substance claim
No
Drug product claim
No
Assignee
Ipsen Biopharm Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.